> top > docs > PMC:7205724 > spans > 280-502 > annotations

PMC:7205724 / 280-502 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
5 51-59 Disease denotes COVID-19 MESH:C000657245
7 134-142 Disease denotes COVID-19 MESH:C000657245
10 147-150 Gene denotes IL6 Gene:3569

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 51-59 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 134-142 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 4-19 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T5 114-129 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 190-200 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T3 4-19 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T4 114-129 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T2 51-59 Species denotes COVID-19 NCBItxid:2697049
T3 134-142 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T7 61-143 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
5 51-59 Disease denotes COVID-19 MESH:C000657245
7 134-142 Disease denotes COVID-19 MESH:C000657245
10 147-150 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 147-150 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T40 1-3 IN denotes of
T41 4-19 NNS denotes corticosteroids
T42 20-25 MD denotes might
T43 26-36 VB denotes accelerate
T44 37-45 NN denotes recovery
T45 46-50 IN denotes from
T46 51-59 NN denotes COVID-19
T47 61-62 PDT denotes •
T48 64-66 DT denotes No
T49 67-77 VBN denotes controlled
T50 78-86 JJ denotes clinical
T51 87-93 NNS denotes trials
T52 94-99 VBP denotes exist
T53 100-102 IN denotes on
T54 103-106 DT denotes the
T55 107-110 NN denotes use
T56 111-113 IN denotes of
T57 114-129 NNS denotes corticosteroids
T58 130-133 IN denotes for
T59 134-142 NN denotes COVID-19
T60 144-145 LS denotes •
T61 147-150 NN denotes IL6
T62 151-161 VBZ denotes correlates
T63 162-166 IN denotes with
T64 167-175 NN denotes severity
T65 175-176 -COMMA- denotes ,
T66 177-188 NN denotes criticality
T67 188-189 -COMMA- denotes ,
T68 190-195 JJ denotes viral
T69 196-200 NN denotes load
T70 200-201 -COMMA- denotes ,
T71 202-205 CC denotes and
T72 206-215 NN denotes prognosis
T73 216-218 IN denotes of
R36 T41 T40 arg2Of corticosteroids,of
R38 T43 T42 arg2Of accelerate,might
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 51-59 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 134-142 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T7 61-143 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.